People · Operator

John Mulligan

Named in public records as an officer, director or promoter · active 2015–2022 · Biotechnology

3
Companies
7
Filings
$77.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bonum Therapeutics, Inc.—BiotechnologySeries C$46.2M$746.1M2021
Good Therapeutics, Inc.—BiotechnologySeries B$31.1M$188.6M2018
Glycostasis, Inc.—BiotechnologyPre-Seed$150K$8.3M2015
Operator network

John Mulligan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Samuel Bjork · 2 companies · 1 sharedSamuel BjorkNICHOLAS WALROD · 8 companies · 2 sharedNICHOLAS WALRODJohn McKearn · 6 companies · 2 sharedJohn McKearnMitchell Mutz · 5 companies · 2 sharedMitchell MutzDiane Hollenbaugh · 3 companies · 2 sharedDiane HollenbaughKarl Handelsman · 3 companies · 2 sharedKarl HandelsmanMonique Schiersing · 2 companies · 2 sharedMonique SchiersingNeela Patel · 2 companies · 2 sharedNeela PatelBonum Therapeutics, Inc. · $46.2M raisedBonum Therapeutics, I…Good Therapeutics, Inc. · $31.1M raisedGood Therapeutics, In…Glycostasis, Inc. · $0.1M raisedGlycostasis, Inc.John MulliganJM
John Mulligan Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John Mulligan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
NICHOLAS WALROD28
John McKearn26
Mitchell Mutz25
Diane Hollenbaugh23
Karl Handelsman23
Neela Patel22
Monique Schiersing22
Samuel Bjork12

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.